WO2025247186 - USE OF ANTI-TROP2 ANTIBODY-DRUG CONJUGATE AND VEGF-A INHIBITOR IN COMBINATION FOR TREATING TUMOR
National phase entry is expected:
Publication Number
WO/2025/247186
Publication Date
04.12.2025
International Application No.
PCT/CN2025/097336
International Filing Date
27.05.2025
Title **
[English]
USE OF ANTI-TROP2 ANTIBODY-DRUG CONJUGATE AND VEGF-A INHIBITOR IN COMBINATION FOR TREATING TUMOR
[French]
UTILISATION D'UN CONJUGUÉ ANTICORPS-MÉDICAMENT ANTI-TROP2 ET D'UN INHIBITEUR DE VEGF-A EN COMBINAISON POUR LE TRAITEMENT D'UNE TUMEUR
[Chinese]
抗TROP2抗体药物偶联物和VEGF-A抑制剂联合治疗肿瘤的用途
Applicants **
BIO-THERA SOLUTIONS, LTD.
Inventors
WANG, Hao
SONG, Shuqiang
Priority Data
202410670803.1
27.05.2024
CN
Application details
| Total Number of Claims/PCT | * |
| Number of Independent Claims | * |
| Number of Priorities | * |
| Number of Multi-Dependent Claims | * |
| Number of Drawings | * |
| Pages for Publication | * |
| Number of Pages with Drawings | * |
| Pages of Specification | * |
| * | |
| Number of Office Actions | * |
| * | |
International Searching Authority |
CNIPA
* |
| Recordal of a Change of the Applicant's Name/Address |
Change of Applicant's Name and Address
* |
| Type of Assignment |
The Standard Agent's Assignment
* |
| Applicant's Legal Status |
Legal Entity
* |
| * | |
| * | |
| * | |
| * | |
| * | |
| Entry into National Phase under |
Chapter I
* |
| Patent Delivery |
Send the Letters Patent by Courier
* |
| Translation |
|
* The data is based on automatic recognition. Please verify and amend if necessary.
** IP-Coster compiles data from publicly available sources. If this data includes your personal information, you can contact us to request its removal.
Quotation for National Phase entry
| Country | Stages | Total | |
|---|---|---|---|
| China | Filing, Examination, Granting | 2112 | |
| EPO | Filing, Examination, Granting | 17970 | |
| Japan | Filing, Examination, Granting | 2543 | |
| South Korea | Filing, Examination, Granting | 2898 | |
| USA | Filing, Examination, Granting | 6140 |
Total:
31,663
Contact Us
Abstract[English]
The present invention relates to a method for treating a tumor using a TROP2-targeting antibody-drug conjugate and a VEGF-A inhibitor in combination or use of the TROP2-targeting antibody-drug conjugate and the VEGF-A inhibitor in combination for treating the tumor.[French]
La présente invention concerne une méthode de traitement d'une tumeur à l'aide d'un conjugué anticorps-médicament ciblant TROP2 et d'un inhibiteur de VEGF-A en combinaison ou l'utilisation du conjugué anticorps-médicament ciblant TROP2 et de l'inhibiteur de VEGF-A en combinaison pour traiter la tumeur.[Chinese]
本发明涉及靶向TROP2的抗体药物偶联物和VEGF-A抑制剂联合用药用于治疗肿瘤的方法或用途。